Alzheimer's & Dementia Journal

•  
• Overview
•  
• Identity
•  
• View All
•  

Overview

publication venue for

• Comparing clinical features of behavioral variant frontotemporal dementia and Alzheimer's disease using network analysis.  21:e70361. 2025
• Sharing health care wishes among older adults with cognitive impairment in primary care: Results from a randomized controlled trial..  20:7263-7273. 2024
• Amyloid PET and clinical management in a diverse, cognitively impaired population: The New IDEAS Study 2025
• Amyloid PET and clinical management in a diverse, cognitively impaired population: The New IDEAS Study 2025
• An international core outcome set for primary progressive aphasia (COS‐PPA): Consensus‐based recommendations for communication interventions across research and clinical settings 2025
• Calibration of multisite raters for prospective visual reads of amyloid PET scans 2025
• Cerebrospinal fluid and brain positron emission tomography measures of synaptic vesicle glycoprotein 2A: Biomarkers of synaptic density in Alzheimer's disease 2025
• Facets of language performance in early‐onset and late‐onset Alzheimer's disease dementia 2025
• Prevalence of dementia diagnoses in a safety net health system 2025
• Sex differences in amyloid PET in a large, real‐world sample from the Imaging Dementia–Evidence for Amyloid Scanning (IDEAS) Study 2025
• Slow wave synchrony during NREM sleep tracks cognitive impairment in prodromal Alzheimer's disease 2025
• A clock model of regional tau‐PET accumulation and cognitive decline in sporadic early‐onset Alzheimer's disease 2024
• A clock model of regional tau‐PET accumulation and cognitive decline in sporadic early‐onset Alzheimer’s disease 2024
• Amyloid‐PET in patients with a clinical diagnosis of sporadic early‐ versus late‐onset AD: comparison of the LEADS and ADNI cohorts 2024
• Amyloid‐PET in patients with a clinical diagnosis of sporadic early‐ versus late‐onset AD: comparison of the LEADS and ADNI cohorts 2024
• Association Between Late‐Life Depression and Amyloid Beta Burden in Older Adults Without Cognitive Impairment: A. Systematic Review and Meta‐Analysis 2024
• Characterization of the heterogeneity of amyloid‐PET‐negative patients with a clinical diagnosis of sporadic early‐onset AD: an FDG‐PET study in the LEADS cohort 2024
• Characterization of the heterogeneity of amyloid‐PET‐negative patients with a clinical diagnosis of sporadic early‐onset AD: an FDG‐PET study in the LEADS cohort 2024
• Childhood adversity predicts worse verbal and visual memory in cognitively intact older White and Latino adults in California 2024
• Clinical Impact of Amyloid PET in Diverse Medicare Beneficiaries with Cognitive Impairment: Preliminary Results from New IDEAS 2024
• Clonal hematopoiesis of indeterminate potential is associated with reduced risk of cognitive impairment in patients with chronic kidney disease. 2024
• Implementation of Blood‐based Biomarkers in a Large Dementia Care Clinic: Case‐based Report from the UCSF Memory and Aging Center 2024
• Learning from Real‐World Data Platforms: Insights into Care and Representation in Research Through ALZ‐NET and New IDEAS 2024
• Residential Neighborhood Disadvantage and Amyloid Positivity: Findings from IDEAS 2024
• Residential Neighborhood Disadvantage and Amyloid Positivity: Findings from IDEAS 2024
• Scalable plasma and digital cognitive markers for diagnosis and prognosis of Alzheimer's disease and related dementias 2024
• Scalable plasma and digital cognitive markers for diagnosis and prognosis of Alzheimer's disease and related dementias 2024
• Sex Differences in Amyloid PET in a Large, Real‐Life Sample from the Imaging Dementia‐Evidence for Amyloid Scanning (IDEAS) Study 2024
• Amyloid and tau-PET in early-onset AD: Baseline data from the Longitudinal Early-onset Alzheimer′s Disease Study (LEADS) 2023
• Amyloid and tau‐PET in early‐onset AD: Baseline data from the Longitudinal Early‐onset Alzheimer's Disease Study (LEADS) 2023
• Amyloid‐, tau‐, and FDG‐PET in amyloid‐negative patients clinically diagnosed with early‐onset Alzheimer’s disease in the LEADS study 2023
• Amyloid‐, tau‐, and FDG‐PET in amyloid‐negative patients clinically diagnosed with early‐onset Alzheimer’s disease in the LEADS study 2023
• Amyloid‐PET, tau‐PET, and their association in sporadic early‐onset Alzheimer’s Disease: Cross‐sectional and longitudinal data from the LEADS study 2023
• Comparison of Expert Reads vs. Local Clinical Reads of Amyloid PET Scans in IDEAS 2023
• Comparison of Expert Reads vs. Local Clinical Reads of Amyloid PET Scans in IDEAS 2023
• Perceptions about Dementia Clinical Trials 2023
• Quantitative Amyloid‐PET in Real‐World Practice: Lessons from the Imaging Dementia—Evidence for Amyloid Scanning (IDEAS) study 2023
• Regional patterns of pathological tau accumulation in sporadic early‐onset Alzheimer’s disease: Longitudinal tau‐PET in the LEADS Cohort 2023
• The development and refinement of the enhancing active caregiver training (EnACT) intervention for caregivers of persons living with dementia 2023
• Towards the future of ADRD diagnosis: combination of a brief digital cognitive battery and plasma biomarkers for diagnosis and prognosis of disease 2023
• 18F‐MK‐6240 Tau PET as a Biomarker for Chronic Traumatic Encephalopathy: Case Series of 10 Symptomatic Former National Football League Players 2022
• Amyloid Negative, Highly Tau Positive: Clinical Characterization of a Rare Biomarker Profile 2022
• Quantitative analysis of 6,150 real‐world amyloid Positron Emission Tomography (PET) scans from the Imaging Dementia–Evidence for Amyloid Scanning (IDEAS) study 2022
• Comparison of plasma and CSF biomarkers across ethnoracial groups in ADNI 2021
• Early detection of dementia and mild cognitive impairment with BrainCheck 2021
• Education differentially contributes to cognitive reserve across racial/ethnic groups 2021
• IDEAS and New IDEAS: Amyloid PET in diverse populations 2021
• Plasma amyloid beta, neurofilament light chain, and total tau in the Systolic Blood Pressure Intervention Trial (SPRINT). 2021
• Perspective on the “African American participation in Alzheimer disease research: Effective strategies” workshop, 2018 2020
• VALIDATION STUDY OF THE GERMAN VERSION OF MONTREAL COGNITIVE ASSESSMENT (MOCA) 2019
• GERMAN NORMATIVE DATA FOR THE MONTREAL COGNITIVE ASSESSMENT 2018
• Standardisation of a novel self-administered screening tool for postoperative delirium: a prospective observational study 2017
• Dexmedetomidine versus propofol-remifentanil based conscious sedation during awake craniotomy for supratentorial tumor resection: a prospective, double-blind, randomized trial 2015
• Monitored anesthesia care during awake craniotomy: a prospective, double-blind, randomized trial comparing the intraoperative use of dexmedetomidine and propofol-remifentanil 2015
• IC-P2-101: Detecting cognitive impairment in patients with metabolic syndrome and mild cognitive impairment by using PET-FDG 2008
• P4-027: Alzheimer's disease a metabolic syndrome hypothesis 2008
• O2-04-06 2007
• P-086 2007
• P-112 2007
• P2-241 2006
• P3‐493: EFFECT OF AGING AND EDUCATION ON LEXICAL PRODUCTION TASKS IN HEALTHY OLDER ADULTS: A LONGITUDINAL STUDY 2006
• A comparative study of mini-mental state exam and the Saint Louis University mental status for detecting mild cognitive impairment 2005
• A systematic examination of exercise training outcomes on cognitively impaired and cognitively intact older adults 2005
• Effects of testosterone supplementation on cognitive functioning in aging men: A systematic review 2005
• Machine learning of transcripts and audio recordings of spontaneous speech for diagnosis of Alzheimer’s disease 2021
• Validation study of the German version of the Montreal Cognitive Assessment (MoCA) 2019
• Differences in normative samples of the Montreal Cognitive Assessment: Call for guidelines 2018
• German normative data for the Montreal Cognitive Assessment (MoCA) 2018
• German normative data for the Montreal Cognitive Assessment (MoCA) 2018
• Predictors of postoperative delirium in patients undergoing cardiac surgery 2017
• Predictors of postoperative delirium in patients undergoing cardiac surgery 2017
• Standardisation of a novel self-administered screening tool for postoperative delirium: a prospective observational study 2017
• Standardisation of a novel self-administered screening tool for postoperative delirium: a prospective observational study 2017
• Dexmedetomidine versus propofol-remifentanil based conscious sedation during awake craniotomy for supratentorial tumor resection: a prospective, double-blind, randomized trial 2015
• Monitored anesthesia care during awake craniotomy: a prospective, double-blind, randomized trial comparing the intraoperative use of dexmedetomidine and propofol-remifentanil 2015

Identity

International Standard Serial Number (ISSN)

• 1552-5260
• 1552-5279